Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Irina Udalova on her successful Wellcome Trust Investigator Award entitled “Molecular control of pathogenic neutrophil responses in inflammation”.

Irina has been awarded £1.5 million over 5 years to research how neutrophil function in the tissue is guided by intrinsic molecular regulators and influenced by extrinsic protein and lipid signals produced by macrophages. Recent work has highlighted a number of factors that will be functionally validated and the hypothesis that neutrophil accumulation and activity in tissues during sterile inflammation is controlled by resident and effector macrophages will be examined. Understanding the control of pathogenic neutrophil responses and identification of key regulators will help to redefine these understudied cells in chronic inflammatory disorders such as such as rheumatoid arthritis, atherosclerosis, diabetes  amongst others and may lead to new treatments reducing the burden of human chronic inflammatory disease.

Speaking of the award, Professor Udalova stated “I am delighted to receive this award as the recognition of our unique expertise in neutrophil genomics, recently developed cutting edge technologies and established key strategic collaborations. I believe our work in this extremely interesting and completely under-studied area of research in neutrophil biology will lead to important and transforming discoveries”.

The grant will start on the 1st February 2018.

Similar stories

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.

New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis

A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Research finds that surgery for Dupuytren’s disease is effective, but repeat operations come with higher risks

Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.

Celebrating World Clubfoot Day

More than 30,000 children in Africa are born with clubfoot each year. With treatment simply not available where they live, many thousands of these children get no treatment and end up with severe deformities that make it hard and very painful to walk.

Repurposed drug can induce remission of inflammatory arthritis

Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.